Targeted Oncology Biologics Market Growth, Company Revenue Share,...

σε πρόσθεσε στο Health

2026-04-15 10:01:28 -

Targeted Oncology Biologics Market Growth, Company Revenue Share, Key Drivers & Trend Analysis By FMI

The global targeted oncology biologics market is poised for robust expansion, projected to grow from USD 74,751.0 million in 2026 to USD 186,948.7 million by 2036, registering a CAGR of 9.6% over the forecast period, according to Future Market Insights (FMI). This growth is driven by the structural shift in oncology care toward molecularly defined treatment pathways, where therapies...

0 Σχόλια 0 Μοιράστηκε 45 Views 0 Προεπισκόπηση